A Study to Evaluate the Safety and Efficacy of AV-1 Against Dengue Virus 3 (DENV-3) Infection

Clinical trial NCT06799741 · COMPLETED

Trial details

NCT number: NCT06799741
Sponsor: AbViro LLC
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

DENV-3 Controlled Human Infection Model

Start date: 2025-01-07
Primary completion: 2026-03-11
Enrollment: 85

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.